Literature DB >> 33412755

Prediction of hub genes of Alzheimer's disease using a protein interaction network and functional enrichment analysis.

Jia Jin Wee1, Suresh Kumar1.   

Abstract

Alzheimer's disease (AD) is a chronic, progressive brain disorder that slowly destroys affected individuals' memory and reasoning faculties, and consequently, their ability to perform the simplest tasks. This study investigated the hub genes of AD. Proteins interact with other proteins and non-protein molecules, and these interactions play an important role in understanding protein function. Computational methods are useful for understanding biological problems, in particular, network analyses of protein-protein interactions. Through a protein network analysis, we identified the following top 10 hub genes associated with AD: PTGER3, C3AR1, NPY, ADCY2, CXCL12, CCR5, MTNR1A, CNR2, GRM2, and CXCL8. Through gene enrichment, it was identified that most gene functions could be classified as integral to the plasma membrane, G-protein coupled receptor activity, and cell communication under gene ontology, as well as involvement in signal transduction pathways. Based on the convergent functional genomics ranking, the prioritized genes were NPY, CXCL12, CCR5, and CNR2.

Entities:  

Keywords:  Alzheimer’s disease; functional enrichment; hub genes; network analysis; protein-protein interaction

Year:  2020        PMID: 33412755      PMCID: PMC7808865          DOI: 10.5808/GI.2020.18.4.e39

Source DB:  PubMed          Journal:  Genomics Inform        ISSN: 1598-866X


  33 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.

Authors:  Onofre Combarros; Jon Infante; Javier Llorca; Nicolás Peña; Carlos Fernández-Viadero; José Berciano
Journal:  Neurosci Lett       Date:  2004-08-19       Impact factor: 3.046

3.  FunRich: An open access standalone functional enrichment and interaction network analysis tool.

Authors:  Mohashin Pathan; Shivakumar Keerthikumar; Ching-Seng Ang; Lahiru Gangoda; Camelia Y J Quek; Nicholas A Williamson; Dmitri Mouradov; Oliver M Sieber; Richard J Simpson; Agus Salim; Antony Bacic; Andrew F Hill; David A Stroud; Michael T Ryan; Johnson I Agbinya; John M Mariadason; Antony W Burgess; Suresh Mathivanan
Journal:  Proteomics       Date:  2015-06-17       Impact factor: 3.984

4.  Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.

Authors:  Alexandra Litvinchuk; Ying-Wooi Wan; Dan B Swartzlander; Fading Chen; Allysa Cole; Nicholas E Propson; Qian Wang; Bin Zhang; Zhandong Liu; Hui Zheng
Journal:  Neuron       Date:  2018-11-08       Impact factor: 17.173

5.  PGE2-EP3 signaling pathway impairs hippocampal presynaptic long-term plasticity in a mouse model of Alzheimer's disease.

Authors:  Vincent Maingret; Gaël Barthet; Séverine Deforges; Nan Jiang; Christophe Mulle; Thierry Amédée
Journal:  Neurobiol Aging       Date:  2016-10-17       Impact factor: 4.673

Review 6.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

7.  Plasma neuropeptide Y is reduced in patients with Alzheimer's disease.

Authors:  S Koide; H Onishi; H Hashimoto; T Kai; S Yamagami
Journal:  Neurosci Lett       Date:  1995-09-29       Impact factor: 3.046

Review 8.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

Review 9.  Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.

Authors:  Han-Chang Huang; Zhao-Feng Jiang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

Authors:  Xiaocong Pang; Ying Zhao; Jinhua Wang; Qimeng Zhou; Lvjie Xu; Ai-Lin Liu; Guan-Hua Du
Journal:  Biomed Res Int       Date:  2017-11-21       Impact factor: 3.411

View more
  2 in total

1.  Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer's Disease, Common to APPV717I × TAUP301L Mice and Patients.

Authors:  Catalina Anca Cucos; Elena Milanesi; Maria Dobre; Ioana Andreea Musat; Gina Manda; Antonio Cuadrado
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

2.  Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease.

Authors:  Natasha Andressa Nogueira Jorge; Uwe Ueberham; Mara Knobloch; Peter F Stadler; Jörg Fallmann; Thomas Arendt
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.